Klinik und Poliklinik für Chirurgie, Universitätsklinikum Regensburg, Franz-Josef-Strauss Allee 11, 93053, Regensburg, Germany.
Langenbecks Arch Surg. 2011 Jan;396(1):3-11. doi: 10.1007/s00423-010-0726-y. Epub 2010 Nov 12.
Mesenteric ischemia is a condition well-known among physicians treating patients with abdominal symptoms. Even so, mortality rates have not decreased significantly over the last decades. The purpose of this article is to review current treatment concepts of acute and chronic mesenteric ischemia.
Early diagnosis is one of the most important features that determine a patient's prognosis. Conventional angiography and multidetector computed tomography are therefore appropriate to quickly diagnose mesenteric ischemia, the latter being commonly more available. Once a patient presents with signs of peritonitis, instant laparotomy is indicated, and infarcted bowel segments need to be resected, followed by a second-look operation if necessary. If bowel necrosis is clinically not suspected, different approaches should be applied according to source and nature of mesenteric ischemia. Besides established surgical treatment concepts, more and more interventional procedures are developed and evaluated. However, superiority of these new techniques could only be shown for selected patient groups so far. In chronic mesenteric ischemia, interventional approaches seem to be an attractive alternative in patients who are in a condition too bad to undergo surgery. Patients with colonic ischemia are treated best in a conservative manner and by resolving the underlying cause, if identified.
Patients with acute mesenteric ischemia are still at highest risk for a fatal course of disease. New diagnostic and therapeutic developments have not been tested in larger studies yet, neither has any of these methods led to an increased survival in studies published so far. Taken together, mesenteric ischemia requires high awareness, earliest possible diagnosis, and treatment by an experienced interdisciplinary team of gastroenterologists, radiologists, and surgeons.
肠系膜缺血是治疗腹痛患者的医生熟知的一种病症。即便如此,过去几十年里死亡率并未显著下降。本文的目的是回顾急性和慢性肠系膜缺血的当前治疗概念。
早期诊断是决定患者预后的最重要特征之一。因此,常规血管造影和多排螺旋 CT 可快速诊断肠系膜缺血,后者通常更常用。一旦患者出现腹膜炎体征,即应立即进行剖腹手术,切除梗死的肠段,如果需要,还需进行二次探查手术。如果临床上不怀疑肠坏死,则应根据肠系膜缺血的来源和性质采用不同的方法。除了既定的手术治疗概念外,越来越多的介入治疗方法正在被开发和评估。然而,迄今为止,这些新技术仅在某些特定患者群体中显示出优势。在慢性肠系膜缺血中,介入治疗方法似乎是一种有吸引力的选择,适用于那些身体状况太差而无法接受手术的患者。如果确定了病因,应通过保守治疗和解决潜在原因来治疗结肠缺血患者。
急性肠系膜缺血患者的疾病致死风险仍然最高。新的诊断和治疗方法尚未在更大规模的研究中进行测试,在迄今为止发表的研究中,这些方法也没有导致生存率的提高。总之,肠系膜缺血需要高度警惕、尽可能早地诊断,并由经验丰富的胃肠病学家、放射科医生和外科医生组成的跨学科团队进行治疗。